Keyword: Pharmaceutical

151 results found

As a job title, ‘drug case manager’ can imply different things across the health-care and benefits industries. In Canada, a drug case manager may be part of a drug manufacturer’s patient support program or an insurance company’s preferred pharmacy network, while hospitals have case managers at various levels, says Suzanne Nagy, drug consulting leader for […]

What are the implications of pharmacare reform for private drug plans?

As the federal government continues its consultations on a national pharmacare system, many questions are still up in the air. Will the new system follow a single-payer model? And if so, what would be the implications for a private-payer system? As discussions examine the various possibilities, the private industry says pharmacare reform is a complex issue that requires more […]

  • By: Jann Lee
  • February 1, 2019 September 13, 2019
  • 09:30
Employers, insurers have role in managing benefits plan sustainability

While insurers are consistently providing innovative plan design options for employers, that doesn’t detract from the reality that it’s a difficult time for employers, according to the Canadian Life and Health Insurance Association’s Karen Voin. “At the heart of it, they want to ensure they’re not impacting their employees, and are really conscious of what the impact […]

More innovative, intensive approach to medication management required

Treating mental health with medications is very different from treating an infection, so why do many people, and many employers, treat them like they’re one and the same? When enhancing communications around wellness programs, plan sponsors should seek innovative ways to support employees with how they use medications and help them understand the interactions between drugs and mental […]

Shoppers Drug Mart launches medical cannabis e-commerce portal

Shoppers Drug Mart’s e-commerce platform for medical cannabis launched Tuesday, a month after Health Canada licensed the company to sell the product online. Product information is available nationally, but Shoppers Drug Mart can initially only sell medical cannabis to patients in Ontario. Patients will be required to take a medical document similar to a prescription […]

Express Scripts Canada appoints new president

Express Scripts Canada is appointing Dr. Dorian Lo as president following Michael Biskey’s retirement from the position in the first quarter of 2019. Lo is a Canadian physician with international experience in health care, pharmacy and pharmacy benefits management. He’s currently managing director of group strategy and health care at Rajawali Corp., an investment holding company in […]

  • By: Staff
  • December 6, 2018 September 13, 2019
  • 15:00
Ontario should act cautiously in allowing private label drugs: CLHIA

The Canadian Life and Health Insurance Association is asking the Ontario government to act cautiously in welcoming private label products under the provincial drug program and allowing them to be interchangeable with other products. Presently, the Ontario Drug Benefit Act doesn’t list private label products as drug products, meaning they’re not eligible for public funding under the drug benefit program. […]

  • By: Jann Lee
  • November 30, 2018 September 13, 2019
  • 09:00
Teladoc Health launches specialty pharmacy service

Virtual health-care company Teladoc Health is launching a specialty pharmacy services product aimed at combatting rising prescription drug costs using analytics and medical opinions. “So many people find themselves taking a medication for an extended period of time with limited or no benefit and without the opportunity to fully understand why or learn of alternatives,” said […]

  • By: Staff
  • November 26, 2018 September 13, 2019
  • 09:56
How NAFTA negotiations could affect drug prices, pharmacare

The results of the ongoing renegotiations of the North American Free Trade Agreement could have an impact on how much Canadians pay for their medications in the future, according to one expert. In an article originally published by not-for-profit media outlet the Conversation, Joel Lexchin, an associate professor of family and community medicine at the University of Toronto, pointed out that the […]

  • By: Staff
  • September 12, 2018 September 13, 2019
  • 09:00

High-cost drugs accounted for 41.6 per cent of patented medicine sales in 2017, up from 8.3 per cent a decade earlier, according to the Patented Medicine Prices Review Board’s latest annual report. Federal Health Minister Ginette Petitpas Taylor tabled the report, which also illustrated a rise in the sales of patented medicines in 2017. Sales […]

  • By: Staff
  • August 24, 2018 March 31, 2021
  • 09:15